NYSE : GRDN
Guardian Pharmacy Services, Inc. — Key statistics
Healthcare · Medical Care Facilities · United States
Last price 40.45 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.56B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 2.58B |
| Enterprise Value | 2.53B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 49.80M |
| Shares Outstanding | 63.34M |
| Shares Change (YoY) | +1.91% |
| Shares Change (QoQ) | +0.22% |
| Owned by Insiders (%) | 16.97% |
| Owned by Institutions (%) | 50.45% |
| Float | 22.38M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 39.30 |
| Forward PE | 30.11 |
| PS Ratio | 1.76 |
| Forward PS | 1.73 |
| PB Ratio | 10.49 |
| P/TBV Ratio | 17.27 |
| P/FCF Ratio | 32.30 |
| P/OCF Ratio | 26.07 |
| PEG Ratio | 1.86 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 38.34 |
| EV / Sales | 1.73 |
| EV / EBITDA | 23.10 |
| EV / EBIT | 29.37 |
| EV / FCF | 31.67 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.65 |
| Quick Ratio | 1.26 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 0.32 |
| Debt / FCF | 0.49 |
| Interest Coverage | 136.36 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 30.42% |
| Return on Assets (ROA) | 13.45% |
| Return on Invested Capital (ROIC) | 28.73% |
| Return on Capital Employed (ROCE) | 29.72% |
| Weighted Average Cost of Capital (WACC) | 4.50% |
| Revenue Per Employee | $406,502 |
| Profits Per Employee | $18,308 |
| Employee Count | 3,600 |
| Asset Turnover | 3.66 |
| Inventory Turnover | 24.25 |
Taxes
| Measure | Value |
|---|
| Income Tax | 29.29M |
| Effective Tax Rate | 30.57% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.05 |
| 52-Week Price Change | +42.52% |
| 50-Day Moving Average | 41.05 |
| 200-Day Moving Average | 38.08 |
| Relative Strength Index (RSI) | 50.57 |
| Average Volume (20 Days) | 376,230 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 2.38M |
| Short Previous Month | 2.43M |
| Short % of Shares Out | 3.76% |
| Short % of Float | 10.65% |
| Short Ratio (days to cover) | 3.76 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.46B |
| Gross Profit | 316.58M |
| Operating Income | 86.04M |
| Pretax Income | 95.82M |
| Net Income | 65.91M |
| EBITDA | 109.41M |
| EBIT | 86.04M |
| Earnings Per Share (EPS) | $1.04 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 89.81M |
| Total Debt | 39.27M |
| Net Cash | 50.54M |
| Net Cash Per Share | $0.80 |
| Equity (Book Value) | 257.64M |
| Book Value Per Share | 3.88 |
| Working Capital | 100.63M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 98.86M |
| Capital Expenditures | -19.07M |
| Depreciation & Amortization | 23.36M |
| Net Borrowing | -4.86M |
| Free Cash Flow | 79.79M |
| FCF Per Share | $1.26 |
Margins
| Measure | Value |
|---|
| Gross Margin | 21.63% |
| Operating Margin | 5.88% |
| Pretax Margin | 6.55% |
| Profit Margin | 4.50% |
| EBITDA Margin | 7.48% |
| EBIT Margin | 5.88% |
| FCF Margin | 5.45% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.91% |
| Shareholder Yield | n/a |
| Earnings Yield | 2.54% |
| FCF Yield | 3.10% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $49.86 |
| Price Target Difference | 22.54% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 5.09% |
| EPS Growth Forecast (3Y) | 14.07% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 10.83 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |